493 related articles for article (PubMed ID: 26457758)
41. Curcuminoids block TGF-β signaling in human breast cancer cells and limit osteolysis in a murine model of breast cancer bone metastasis.
Wright LE; Frye JB; Lukefahr AL; Timmermann BN; Mohammad KS; Guise TA; Funk JL
J Nat Prod; 2013 Mar; 76(3):316-21. PubMed ID: 23145932
[TBL] [Abstract][Full Text] [Related]
42. Attenuated Ca(2+) release in a mouse model of limb girdle muscular dystrophy 2A.
DiFranco M; Kramerova I; Vergara JL; Spencer MJ
Skelet Muscle; 2016; 6():11. PubMed ID: 26913171
[TBL] [Abstract][Full Text] [Related]
43. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
[TBL] [Abstract][Full Text] [Related]
44. Rem uncouples excitation-contraction coupling in adult skeletal muscle fibers.
Beqollari D; Romberg CF; Filipova D; Meza U; Papadopoulos S; Bannister RA
J Gen Physiol; 2015 Jul; 146(1):97-108. PubMed ID: 26078055
[TBL] [Abstract][Full Text] [Related]
45. Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12.
Shou W; Aghdasi B; Armstrong DL; Guo Q; Bao S; Charng MJ; Mathews LM; Schneider MD; Hamilton SL; Matzuk MM
Nature; 1998 Jan; 391(6666):489-92. PubMed ID: 9461216
[TBL] [Abstract][Full Text] [Related]
46. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.
Deckers M; van Dinther M; Buijs J; Que I; Löwik C; van der Pluijm G; ten Dijke P
Cancer Res; 2006 Feb; 66(4):2202-9. PubMed ID: 16489022
[TBL] [Abstract][Full Text] [Related]
47. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro.
Yoneda T; Williams PJ; Hiraga T; Niewolna M; Nishimura R
J Bone Miner Res; 2001 Aug; 16(8):1486-95. PubMed ID: 11499871
[TBL] [Abstract][Full Text] [Related]
48. Sclerostin induced tumor growth, bone metastasis and osteolysis in breast cancer.
Zhu M; Liu C; Li S; Zhang S; Yao Q; Song Q
Sci Rep; 2017 Sep; 7(1):11399. PubMed ID: 28900298
[TBL] [Abstract][Full Text] [Related]
49. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models.
Li Y; Drabsch Y; Pujuguet P; Ren J; van Laar T; Zhang L; van Dam H; Clément-Lacroix P; Ten Dijke P
Breast Cancer Res; 2015 Feb; 17(1):28. PubMed ID: 25849225
[TBL] [Abstract][Full Text] [Related]
50. A Role for TGFβ Signaling in Preclinical Osteolytic Estrogen Receptor-Positive Breast Cancer Bone Metastases Progression.
Cheng JN; Frye JB; Whitman SA; Kunihiro AG; Pandey R; Funk JL
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923316
[TBL] [Abstract][Full Text] [Related]
51. Loss of TGF-β signaling in osteoblasts increases basic-FGF and promotes prostate cancer bone metastasis.
Meng X; Vander Ark A; Daft P; Woodford E; Wang J; Madaj Z; Li X
Cancer Lett; 2018 Apr; 418():109-118. PubMed ID: 29337106
[TBL] [Abstract][Full Text] [Related]
52. Respiratory muscle contractile inactivity induced by mechanical ventilation in piglets leads to leaky ryanodine receptors and diaphragm weakness.
Matecki S; Jung B; Saint N; Scheuermann V; Jaber S; Lacampagne A
J Muscle Res Cell Motil; 2017 Feb; 38(1):17-24. PubMed ID: 28260211
[TBL] [Abstract][Full Text] [Related]
53. A cross-species analysis of a mouse model of breast cancer-specific osteolysis and human bone metastases using gene expression profiling.
Sadanandam A; Futakuchi M; Lyssiotis CA; Gibb WJ; Singh RK
BMC Cancer; 2011 Jul; 11():304. PubMed ID: 21774828
[TBL] [Abstract][Full Text] [Related]
54. Muscle Weakness in Rheumatoid Arthritis: The Role of Ca
Yamada T; Steinz MM; Kenne E; Lanner JT
EBioMedicine; 2017 Sep; 23():12-19. PubMed ID: 28781131
[TBL] [Abstract][Full Text] [Related]
55. Breast cancer cells induce osteoclast formation by stimulating host IL-11 production and downregulating granulocyte/macrophage colony-stimulating factor.
Morgan H; Tumber A; Hill PA
Int J Cancer; 2004 May; 109(5):653-60. PubMed ID: 14999770
[TBL] [Abstract][Full Text] [Related]
56. Gene profiling of embryonic skeletal muscle lacking type I ryanodine receptor Ca(2+) release channel.
Filipova D; Walter AM; Gaspar JA; Brunn A; Linde NF; Ardestani MA; Deckert M; Hescheler J; Pfitzer G; Sachinidis A; Papadopoulos S
Sci Rep; 2016 Feb; 6():20050. PubMed ID: 26831464
[TBL] [Abstract][Full Text] [Related]
57. RyR1 modulation by oxidation and calmodulin.
Hamilton SL; Reid MB
Antioxid Redox Signal; 2000; 2(1):41-5. PubMed ID: 11232598
[TBL] [Abstract][Full Text] [Related]
58. Combined treatment with a transforming growth factor beta inhibitor (1D11) and bortezomib improves bone architecture in a mouse model of myeloma-induced bone disease.
Nyman JS; Merkel AR; Uppuganti S; Nayak B; Rowland B; Makowski AJ; Oyajobi BO; Sterling JA
Bone; 2016 Oct; 91():81-91. PubMed ID: 27423464
[TBL] [Abstract][Full Text] [Related]
59. Targeted inhibition of TGF-β results in an initial improvement but long-term deficit in force production after contraction-induced skeletal muscle injury.
Gumucio JP; Flood MD; Phan AC; Brooks SV; Mendias CL
J Appl Physiol (1985); 2013 Aug; 115(4):539-45. PubMed ID: 23766498
[TBL] [Abstract][Full Text] [Related]
60. Mouse model of severe recessive RYR1-related myopathy.
Brennan S; Garcia-Castañeda M; Michelucci A; Sabha N; Malik S; Groom L; Wei LaPierre L; Dowling JJ; Dirksen RT
Hum Mol Genet; 2019 Sep; 28(18):3024-3036. PubMed ID: 31107960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]